Mainz Biomed N.V. (BST: 4TO)
Germany
· Delayed Price · Currency is EUR
6.64
-0.10 (-1.48%)
At close: Dec 5, 2024
Mainz Biomed Employees
As of December 31, 2023, Mainz Biomed had 71 total employees, including 65 full-time and 6 part-time employees. The number of employees increased by 7 or 10.94% compared to the previous year.
Employees
71
Change (1Y)
7
Growth (1Y)
10.94%
Revenue / Employee
€12,589
Profits / Employee
€308,906
Market Cap
9.70M
Employees Chart
Employees History
Date | Employees | Change | Growth |
---|---|---|---|
Dec 31, 2023 | 71 | 7 | 10.94% |
Dec 31, 2022 | 64 | - | - |
Related Stocks
Company Name | Employees |
---|---|
SAP SE | 107,602 |
Siemens Aktiengesellschaft | 327,000 |
Deutsche Telekom AG | 199,652 |
Allianz SE | 157,883 |
Münchener Rückversicherungs-Gesellschaft Aktiengesellschaft in München | 42,812 |
Merck KGaA | 62,908 |
Siemens Healthineers AG | 72,000 |
Mercedes-Benz Group AG | 166,056 |
Mainz Biomed News
- 2 days ago - Mainz Biomed N.V. Regains Compliance with Nasdaq Capital Market Listing Requirements - GlobeNewsWire
- 8 days ago - EQS-News: Mainz Biomed Initiates U.S. Clinical Study to Evaluate Performance of Next Generation Test on Advanced Adenomas over Large Patient Population - Wallstreet:Online
- 8 days ago - Mainz Biomed Initiates U.S. Clinical Study to Evaluate Performance of Next Generation Test on Advanced Adenomas over Large Patient Population - Wallstreet:Online
- 8 days ago - Mainz Biomed Initiates U.S. Clinical Study to Evaluate Performance of Next Generation Test on Advanced Adenomas over Large Patient Population - GlobeNewsWire
- 5 weeks ago - Quest Diagnostics deal sends Mainz higher - Seeking Alpha
- 5 weeks ago - Mainz Biomed Forms Agreement with Quest Diagnostics to Provide Clinical Trials Laboratory Services for Colorectal Cancer Screening Test - GlobeNewsWire
- 5 weeks ago - EQS-News: Mainz Biomed Forms Agreement with Quest Diagnostics to Provide Clinical Trials Laboratory Services for Colorectal Cancer Screening Test - Wallstreet:Online
- 6 weeks ago - Mainz Biomed Announces Closing of $8.0 Million Follow-On Offering - GlobeNewsWire